We have detected that you are using an Ad Blocker. PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
Explore
Metastatic Breast Cancer
Center of Excellence
Interested in receiving weekly updates about the Metastatic Breast Cancer Center of Excellence?
You can find your saved items on your dashboard, in the "saved" tab.
You've recommended your first item
Your recommendations help us improve our content suggestions for you and other PracticeUpdate members.
You've subscribed to your first topic alert
What does that mean?
Each day, we'll check to see if new items have been published to the topics you're subscribed to, and we'll send you one email with all of the new items from that day.
We'll keep all topic alert notifications available on your dashboard for 30 days, to make sure you don't miss anything.
Lastly, whenever you have unread items in the topics you've subscribed to, the "Alerts" icon will light up in the main menu. Just click on the bell to see your five most-recent, unread notifications.
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
No comments yet, be the first to start the discussion!
Joaquin Gonzalez
Mar 12, 2018
Buenos días, creo que esta señora debe llevar un tratamiento adyuvante hormonal que debe ser evaluado según su estado menopausico, gracias, que de Ud Dr. Joaquin
Luca Licata
Mar 16, 2018
Considering her young age and recurrence score, probably the patient would also benefit from adjuvant chemotherapy
Sewa Legha
Mar 16, 2018
This is a high risk breast Cancer. I would treat this patient with both Chemotherapy and Hormonal therapy. My choice of Chemotherapy would be AC x4 followed by Tamoxifen for 5 years. I would be curious about the opinions of my peers.
Moz Al ameri
Mar 17, 2018
High recurrance scor. I will give 4 cycle of AC Followed by 12 taxol then adjuvante hormonal therapy
Radiation can be questionable, but i will omit it
Bello Inua
Mar 17, 2018
Adjuvant chemotherapy followed by hormonal therapy.
Sewa Legha
Mar 17, 2018
Adding Taxol to 4 cycles of AC regimen for this patient would be excessive as Taxol is approved for lymph node positive breast cancer which is not the case with this patient's breast Cancer. I would welcome other's comments
Eugen Carasevici
Mar 19, 2018
Six CAF cycles followed by radiotherapy
Luca Licata
Mar 20, 2018
This is a young patient with a high predicted risk of relapse. It is a patient who MUST be definitively cured. Why don't you offer the best chemotherapy possible? In my opinion, she undoubtedly deserves a sequential anthracyclines-taxanes chemotherapy
MUFID ELMISTIRI
Mar 26, 2018
I will discuss with patient the option of chemotherapy ACx4 followed by hormone therapy, I believe there is no need for Radiotherapy.
le ha
Mar 26, 2018
I choice 4 cycles of AC regimen, followed by radiation and horminal therapy
Oda Abushaban
Apr 08, 2018
Complex treatment chemo-radiotherapy+hormone anti estrogen
Apr 23, 2024
Pending Moderator approval.
Are you sure you want to delete this comment? This can't be undone.
Sameer
Nasir
MD
Joaquin Gonzalez
Mar 12, 2018
Luca Licata
Mar 16, 2018
Sewa Legha
Mar 16, 2018
Moz Al ameri
Mar 17, 2018
Bello Inua
Mar 17, 2018
Sewa Legha
Mar 17, 2018
Eugen Carasevici
Mar 19, 2018
Luca Licata
Mar 20, 2018
MUFID ELMISTIRI
Mar 26, 2018
le ha
Mar 26, 2018
Oda Abushaban
Apr 08, 2018
Apr 23, 2024
Pending Moderator approval.